03.18.24 -- Relational Risk Analysis For The Bio/Pharma Industry

Examine the technologies underpinning the current sensors being utilized in dissolved CO₂ measurement devices and determine which sensors are appropriate for your application.

BsAbs’ dual specificity opens a wide range of applications. Understand why consistent production of structurally complex molecules that exhibit high yield and purity requires keen expertise and experience.

Explore the use of transposase/transposon systems in the biotech industry, particularly in the development of stable cell lines for protein manufacturing.

Gain insight into how digital standardized tools can streamline your scaling processes and enable more accurate prediction and visualization of your scaling needs.

Process validation is a critical step in the successful commercialization of a new biopharmaceutical. Learn about the challenges and the importance of applying it throughout the entire product life cycle.

Learn about an icIEF-based fractionation platform that can be used to collect protein variants and enable downstream analysis of the variants with techniques such as mass spectrometry.

This discussion on orthogonal methods, such as immunoaffinity chromatography and mass spectrometry, provides a deeper understanding of HCPs that impact patient safety and drug stability.

Realizing the potential of next-generation molecules calls on appropriate expression technologies and development processes that can facilitate their path to market.

Compare manually washed labware and labware cleaned in automatic washing systems to see how the challenges of manual washing can impact your lab's efficacy and repeatability.

Learn about different regulatory pathways manufacturers have taken for introducing biopharmaceutical process improvements and alternate sources of chromatography resins.

Why are scalability and flexibility so important when choosing an early-stage manufacturing strategy, and how does that decision impact financial outcomes for a drug development program?

The future of conjugation and PEGylation in biologics is promising. Understand the key focus areas for PEGylated proteins.

Delve into the intricacies of a successful CDMO relationship and learn how a collaborative approach built on shared goals and open communication can maximize the potential of your cell therapy program.

Understanding the Fc region of your antibody is crucial for assessing the impact on immunology, safety, and efficacy. Explore how to determine the most efficient way to test functionality.